市場調查報告書
商品編碼
1466677
微流體市場:按材料、組件、應用和最終用戶分類 - 2024-2030 年全球預測Microfluidics Market by Material (Glass-based, Polymer-based, Silicon-based), Component (Micro Needle, Micro Pump, Microfluidic Chip), Application, End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年微流體市場規模為255.3億美元,預計2024年將達318.4億美元,2030年將達1243.1億美元,複合年成長率為25.37%。
微流體是一個跨學科的科學領域,涉及微尺度(通常從微升到皮升)流體的精確控制、操作和分析。微流體整合了物理、工程、化學和生物學等各個領域的原理,有助於使用具有數十至數百微米。全球生命科學研究投資的增加正在加速對創新工具和技術的需求。微流體裝置具有高通量篩檢能力和小體積流體處理的精確控制等優點,使其成為對研究人員有吸引力的工具。以精準醫療為重點的醫療保健基礎設施的進步也有助於微流體技術擴大採用用於診斷目的。然而,設計、製造和將微流體裝置整合到目前實驗室工作流程中所涉及的複雜性,以及不同製造方法帶來的標準化問題,極大地阻礙了微流體的使用。製造商正在專注於開發穿戴式診斷設備,利用微流體技術即時監測患者健康狀況。
主要市場統計 | |
---|---|
基準年[2023] | 255.3億美元 |
預測年份 [2024] | 318.4億美元 |
預測年份 [2030] | 1243.1億美元 |
複合年成長率(%) | 25.37% |
材料:微流體裝置更多使用玻璃和矽基材料
玻璃因其優異的光學透明性、高耐化學性和生物相容性而成為微流體裝置的首選。基於聚合物的微流體裝置具有製造成本較低、技術製造容易和設計靈活性等優點。矽廣泛應用於微電子領域,是整合感測器、致動器和其他電子機械系統 (MEMS) 組件的理想選擇。矽基微流體具有尺寸精度高、表面粗糙度低以及與標準半導體製造流程相容等優點。
組成部分:透過使用微針和幫浦將感染風險降至最低
微針是用於各種醫療應用的微創設備,包括藥物輸送、疫苗接種和診斷。與傳統的皮下注射針相比,微針因其無痛給藥、感染風險最小以及組織損傷減少而成為基於需求的偏好。微型泵浦在微流體中至關重要,它允許在微尺度上傳輸、計量和混合流體。微流體晶片是微流體系統的支柱,能夠整合各種組件來執行複雜的流體操縱任務。
應用:微流體裝置在體外診斷與治療的重要應用
體外診斷 (IVD) 透過提供疾病檢測、預防和管理訊息,在醫療保健系統中發揮重要作用。微流體由於能夠操縱少量液體,允許快速分析並提高診斷分析的靈敏度,從而徹底改變了 IVD。微流體在簡化藥物和生命科學研究方法(例如藥物發現、細胞生物學研究、基因組/蛋白質組分析和合成生物學應用)方面具有巨大潛力。使用微流體平台的優點是減少試劑消費量、更快的反應時間、精確控制實驗條件以及在單一晶片/平台上整合多種功能。微流體具有透過藥物傳輸系統、個人化醫療、再生醫學和組織工程的創新來徹底改變治療方法的巨大潛力。在微尺度上特異性控制流體流動的能力使得能夠開發針對特定細胞和組織的新治療解決方案,從而減少與全身給藥相關的副作用。
最終用戶:研究機構、醫院和診斷中心微流體的新用例
學術和研究機構正在將微流體用於生物科學、材料科學和化學工程實驗。這些最終用戶需要精確控制流體、結果的高再現性以及減少樣品體積。醫院和診斷機構正在透過需要快速分析體液中的生物標記和其他分析物的照護現場(POC) 診斷從微流體技術中受益。微流體正在徹底改變製藥和生物技術產業的藥物開發和製造流程。
區域洞察
在美洲,美國和加拿大已成為微流體市場的主要參與者。美國國立衛生研究院 (NIH) 正在大力投資微流體研究,以推進個人化醫療並開發創新的診斷解決方案。中國、日本和印度等國家在亞太地區展現出微流體的巨大成長潛力。在中國,許多在政府支持下的研究機構正致力於開發新的微流體平台,用於臨床診斷和環境監測等應用。歐盟(EU)國家為微流體技術的發展做出了巨大貢獻,許多學術機構與工業界密切合作以實現商業化。在中東和非洲地區,人們對採用尖端醫療技術(包括微流體)用於診斷目的越來越感興趣。沙烏地阿拉伯和阿拉伯聯合大公國等國家正在投資最先進的醫療設施,這些設施利用實驗室晶片系統等先進工具來幫助更快地檢測疾病。
FPNV定位矩陣
FPNV定位矩陣對於評估微流體市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對微流體市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.微流體市場的市場規模與預測是多少?
2.微流體市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些?
3.微流體市場的技術趨勢與法規結構是什麼?
4.微流體市場主要廠商的市場佔有率為何?
5. 進入微流體市場的合適形式和策略手段是什麼?
[183 Pages Report] The Microfluidics Market size was estimated at USD 25.53 billion in 2023 and expected to reach USD 31.84 billion in 2024, at a CAGR 25.37% to reach USD 124.31 billion by 2030.
Microfluidics is a multidisciplinary scientific field that deals with the precise control, manipulation, and analysis of fluids at a microscale level, typically in microliters to picoliters. Microfluidics integrates principles from diverse disciplines such as physics, engineering, chemistry, and biology to facilitate operations on small volumes of fluids using microfabricated devices featuring channels with dimensions ranging from tens to hundreds of micrometers. Increasing global investments in life sciences research have accelerated the demand for innovative tools and technologies. Microfluidic devices offer advantages such as high throughput screening capabilities and precise control over fluid handling at low volumes, making them attractive tools for researchers. Advances in healthcare infrastructure focusing on precision medicine have also contributed to an increased adoption of microfluidic technologies for diagnostic purposes. However, the complexity associated with designing, fabricating, and integrating microfluidic devices into current laboratory workflows and standardization issues arising due to different fabrication methods significantly impedes the usage of microfluidics. In addition, manufacturers focus on developing wearable diagnostic devices that employ microfluidic technologies to monitor patients' health in real-time.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 25.53 billion |
Estimated Year [2024] | USD 31.84 billion |
Forecast Year [2030] | USD 124.31 billion |
CAGR (%) | 25.37% |
Material: Increasing use of glass and silicon-based materials for microfluidic devices
Glass is preferred for microfluidic devices due to its excellent optical transparency properties, high chemical resistance, and biocompatibility. Polymer-based microfluidic devices offer advantages such as lower manufacturing costs, ease of fabrication through techniques, and flexibility in design. Silicon is widely used in microelectronics and is ideal for integrating sensors, actuators, and other microelectromechanical systems (MEMS) components. Silicon-based microfluidics offer advantages such as high dimensional accuracy, low surface roughness, and compatibility with standard semiconductor fabrication processes.
Component: Adoption of microneedles and pumps for minimal risk of infection
Microneedles are minimally invasive devices for various medical applications such as drug delivery, vaccination, and diagnostics. The need-based preference for microneedles is driven by painless drug administration, minimal risk of infection, and reduced tissue damage compared to traditional hypodermic needles. Micropumps are essential in microfluidics, enabling fluid transportation, metering, and mixing at the microscale. Microfluidic chips are the backbone of microfluidic systems, enabling the integration of various components to perform complex fluid manipulation tasks.
Application: Significant application of microfluidic devices in IVD and therapeutics
In-vitro diagnostics (IVD) play a crucial role in healthcare systems by providing information for disease detection, prevention, and management. Microfluidics has revolutionized IVD by enabling rapid analyses and enhanced sensitivity in diagnostic assays with its ability to manipulate small volumes of fluid. Microfluidics has immense potential to streamline pharmaceutical and life science research processes such as drug discovery, cell biology studies, genomics/proteomics analysis, and synthetic biology applications. The advantages of using microfluidic platforms are reduced reagent consumption, faster reaction times, precise control over experimental conditions, and integration of multiple functionalities on a single chip/platform. Microfluidics holds significant potential to revolutionize therapeutics through innovations in drug delivery systems, personalized medicine, regenerative medicine, and tissue engineering. The ability to specifically control fluid flow at the microscale enables the development of novel therapeutic solutions targeting specific cells or tissues, reducing side effects associated with systemic administration.
End User: Emerging use of microfluidics in research organizations and hospitals & diagnostics centers
Academic institutions and research organizations rely on microfluidics to conduct biosciences, material sciences, and chemical engineering experiments. These end users require precise control over fluids, high reproducibility of results, and reduced sample volume consumption. Hospitals and diagnostic facilities benefit from microfluidic technology through point-of-care (POC) diagnostics requiring rapid analysis of biomarkers or other analytes in body fluids. Microfluidics is revolutionizing drug development and manufacturing processes within the pharmaceutical and biotechnology industries.
Regional Insights
In the Americas, the United States and Canada emerged as key players in the microfluidics market due to their robust healthcare infrastructure and strong focus on research, which has led to increased investment from the public and private sectors. The National Institutes of Health (NIH) invests heavily in microfluidics research to advance personalized medicine and develop innovative diagnostic solutions. Countries such as China, Japan, and India showcase immense growth potential in microfluidics in the Asia-Pacific region. In China, numerous research institutions backed by government initiatives focus on developing novel microfluidic platforms for applications such as clinical diagnostics and environmental monitoring. European Union (EU) countries contribute significantly to developing microfluidics technologies, with numerous academic institutions working closely with industries for commercialization. The MEA region is developing interest in adopting cutting-edge medical technologies, including microfluidics, for diagnostic purposes. Countries, including Saudi Arabia and the UAE, have invested in state-of-the-art healthcare facilities that utilize advanced tools such as lab-on-a-chip systems for rapid disease detection.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Microfluidics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Microfluidics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Microfluidics Market, highlighting leading vendors and their innovative profiles. These include Abaxis, Inc., Abbott Laboratories, AbCellera Biologics Inc., Achira Labs Pvt. Ltd., Agilent Technologies, Inc., Ascent Bio-Nano Technologies, Inc., Bio-Rad Laboratories, Inc., BioFluidica, Biosurfit SA, Camozzi Automation S.p.A., Cellix Limited, Danaher Corporation, Dolomite Microfluidics, Elvesys Group, Fluidigm Corporation by Standard BioTools Inc., Fluigent S.A., Idex Corporation, Illumina, Inc., IMT Masks and Divisions AG, Koninklijke Philips N.V., Micropoint Bioscience, Inc., Mission Bio, Inc., NanoCellect Biomedical., OPKO Health, Inc., Parker-Hannifin Corporation, PerkinElmer Inc., Quidel Corporation, SMC Corporation, Sphere Fluidics Limited, and Thermo Fisher Scientific, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Microfluidics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Microfluidics Market?
3. What are the technology trends and regulatory frameworks in the Microfluidics Market?
4. What is the market share of the leading vendors in the Microfluidics Market?
5. Which modes and strategic moves are suitable for entering the Microfluidics Market?